| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |